Role for sentinel lymph node dissection in the management of large (> or = 5 cm) invasive breast cancer.

PubWeight™: 1.61‹?› | Rank: Top 4%

🔗 View Article (PMID 11597008)

Published in Ann Surg Oncol on October 01, 2001

Authors

M H Chung1, W Ye, A E Giuliano

Author Affiliations

1: Joyce Eisenberg Keefer Breast Center. John Wayne Cancer Institute at Saint John's Health Center, Santa Monica, California 90404, USA.

Associated clinical trials:

Axillary Sentinel Lymph Node Detection in Breast Cancers > 2 cm (GAS2PLUS) | NCT00636467

Articles citing this

Diagnostic value of full-dose FDG PET/CT for axillary lymph node staging in breast cancer patients. Eur J Nucl Med Mol Imaging (2009) 2.67

Clinicopathologic factors associated with false-negative sentinel lymph-node biopsy in breast cancer. Ann Surg (2005) 1.17

Contraindications of sentinel lymph node biopsy: are there any really? World J Surg Oncol (2007) 1.00

Sentinel lymph node biopsy before versus after neoadjuvant chemotherapy for breast cancer. Surg Today (2011) 0.87

The accuracy of sentinel node mapping according to T stage in patients with gastric cancer. Gastric Cancer (2010) 0.86

The clinical value of hybrid sentinel lymphoscintigraphy to predict metastatic sentinel lymph nodes in breast cancer. Nucl Med Mol Imaging (2014) 0.80

Timing of determining axillary lymph node status when neoadjuvant chemotherapy is used. Curr Oncol Rep (2014) 0.79

Impact of patient- and disease-specific factors on SLNB in breast cancer patients. Are current guidelines justified? World J Surg (2007) 0.78

What is the burden of axillary disease after neoadjuvant therapy in women with locally advanced breast cancer? Curr Oncol (2013) 0.78

Multifocality and multicentricity are not contraindications for sentinel lymph node biopsy in breast cancer surgery. World J Surg Oncol (2006) 0.77

Swedish prospective multicenter trial evaluating sentinel lymph node biopsy after neoadjuvant systemic therapy in clinically node-positive breast cancer. Breast Cancer Res Treat (2017) 0.75

Expanding indications for lymphatic mapping and sentinel lymph node biopsy in the breast cancer population. Ann Surg Oncol (2001) 0.75

Sentinel node biopsy for breast cancer: is it already a standard of care? A survey of current practice in an Italian region. BMC Cancer (2004) 0.75

A Comparative Validation of Primary Surgical Versus Post-neo-adjuvant Chemotherapy Sentinel Lymph Node Biopsy for Stage III Breast Cancers. World J Surg (2016) 0.75

Articles by these authors

An STS-based map of the human genome. Science (1995) 17.72

Prospective observational study of sentinel lymphadenectomy without further axillary dissection in patients with sentinel node-negative breast cancer. J Clin Oncol (2000) 3.13

Longitudinal cognitive decline is associated with fibrillar amyloid-beta measured by [11C]PiB. Neurology (2010) 2.92

Waterborne outbreak of rotavirus diarrhoea in adults in China caused by a novel rotavirus. Lancet (1984) 2.82

Opium, tobacco, and alcohol use in relation to oesophageal squamous cell carcinoma in a high-risk area of Iran. Br J Cancer (2008) 2.79

Ecological genomics of marine Roseobacters. Appl Environ Microbiol (2007) 2.68

Histopathologic validation of the sentinel lymph node hypothesis for breast carcinoma. Ann Surg (1997) 2.49

Inverse association between intake of cereal fiber and risk of gastric cardia cancer. Gastroenterology (2001) 2.30

Intraoperative examination of the sentinel lymph node for breast carcinoma staging. Am J Clin Pathol (1999) 2.23

Perforin, a cytotoxic molecule which mediates cell necrosis, is not required for the early control of mycobacterial infection in mice. Infect Immun (1997) 2.19

An estimate of amyotrophic lateral sclerosis heritability using twin data. J Neurol Neurosurg Psychiatry (2010) 2.14

The prevalence of carcinoma in palpable vs impalpable, mammographically detected lesions. AJR Am J Roentgenol (1991) 1.91

Limitations of specific reverse-transcriptase polymerase chain reaction markers in the detection of metastases in the lymph nodes and blood of breast cancer patients. J Clin Oncol (1998) 1.90

Optimal histopathologic examination of the sentinel lymph node for breast carcinoma staging. Am J Surg Pathol (1999) 1.82

Do all patients with sentinel node metastasis from breast carcinoma need complete axillary node dissection? Ann Surg (1999) 1.77

Characterization of the human suppressor of fused, a negative regulator of the zinc-finger transcription factor Gli. J Cell Sci (1999) 1.74

DNA methylation profiles in diffuse large B-cell lymphoma and their relationship to gene expression status. Leukemia (2008) 1.70

Risk of hypertension amongst Swedish male snuff users: a prospective study. J Intern Med (2008) 1.69

Sentinel-lymph-node biopsy for breast cancer--not yet the standard of care. N Engl J Med (1998) 1.54

The rationale for planned reoperation after unplanned total excision of soft-tissue sarcomas. J Clin Oncol (1985) 1.54

Accumulation of glucosylceramides in multidrug-resistant cancer cells. J Biol Chem (1996) 1.54

Pelvic support, pelvic symptoms, and patient satisfaction after colpocleisis. Int Urogynecol J Pelvic Floor Dysfunct (2008) 1.54

Ceramide glycosylation potentiates cellular multidrug resistance. FASEB J (2001) 1.53

Use of aspiration cytology and frozen section examination for management of benign and malignant thyroid nodules. Cancer (1991) 1.53

The role of sentinel lymph node biopsy in patients with differentiated thyroid carcinoma. Eur J Surg Oncol (2006) 1.51

Lifestyle related risk factors in the aetiology of gastro-oesophageal reflux. Gut (2004) 1.47

Measurement of the W boson mass with the D0 detector. Phys Rev Lett (2012) 1.46

Does sentinel lymphadenectomy improve staging and alter therapy in elderly women with breast cancer? Ann Surg Oncol (2000) 1.41

Expression of glucosylceramide synthase, converting ceramide to glucosylceramide, confers adriamycin resistance in human breast cancer cells. J Biol Chem (1999) 1.37

Agents that reverse multidrug resistance, tamoxifen, verapamil, and cyclosporin A, block glycosphingolipid metabolism by inhibiting ceramide glycosylation in human cancer cells. J Biol Chem (1997) 1.35

Pathologic features associated with nonsentinel lymph node metastases in patients with metastatic breast carcinoma in a sentinel lymph node. Cancer (2000) 1.34

Long-term use of Swedish moist snuff and the risk of myocardial infarction amongst men. J Intern Med (2007) 1.32

Taxol-induced ceramide generation and apoptosis in human breast cancer cells. Cancer Chemother Pharmacol (2001) 1.32

Body mass and reflux oesophagitis: an oestrogen-dependent association? Scand J Gastroenterol (2002) 1.31

Meta-analysis of postoperative morbidity and perioperative mortality in patients receiving neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal and gastro-oesophageal junctional cancers. Br J Surg (2014) 1.30

Monocyte chemoattractant protein-1 expressed in neurons and astrocytes during focal ischemia in mice. Brain Res (2001) 1.29

Clinical aspects of unknown primary melanoma. Ann Surg (1980) 1.27

Apigenin inhibits growth and induces G2/M arrest by modulating cyclin-CDK regulators and ERK MAP kinase activation in breast carcinoma cells. Anticancer Res (2001) 1.24

Prevalence of gastro-oesophageal reflux symptoms and the influence of age and sex. Scand J Gastroenterol (2004) 1.23

Tamoxifen exposure and risk of oesophageal and gastric adenocarcinoma: a population-based cohort study of breast cancer patients in Sweden. Br J Cancer (2006) 1.22

A YAC-based physical map of the mouse genome. Nat Genet (1999) 1.22

Melanoma from unknown primary site and amelanotic melanoma. Semin Oncol (1982) 1.20

Nationwide study of cancer risk among hip replacement patients in Sweden. J Natl Cancer Inst (2001) 1.19

Dietary antioxidant intake and the risk of cardia cancer and noncardia cancer of the intestinal and diffuse types: a population-based case-control study in Sweden. Int J Cancer (2000) 1.18

Intraoperative lymphatic mapping and sentinel lymph node dissection in breast cancer. CA Cancer J Clin (2000) 1.16

Multispecies coexistence of trees in tropical forests: spatial signals of topographic niche differentiation increase with environmental heterogeneity. Proc Biol Sci (2013) 1.15

Inhibition of TNFalpha attenuates infarct volume and ICAM-1 expression in ischemic mouse brain. Neuroreport (1998) 1.15

Characterization of a human follicular thyroid carcinoma cell line (UCLA RO 82 W-1). Virchows Arch B Cell Pathol Incl Mol Pathol (1989) 1.15

Occult metastases in the axillary lymph nodes of patients with breast cancer node negative by clinical and histologic examination and conventional histology. Dis Markers (1992) 1.14

Observation of the breast cancer patient with a tumor-positive sentinel node: implications of the ACOSOG Z0011 trial. Semin Surg Oncol (2001) 1.13

The seven-transmembrane receptor smoothened cell-autonomously induces multiple ventral cell types. Nat Neurosci (2000) 1.13

Progress in parasitic plant biology: host selection and nutrient transfer. Plant Biol (Stuttg) (2006) 1.13

Glucosylceramide: a marker for multiple-drug resistant cancers. Anticancer Res (1998) 1.12

Sentinel lymphadenectomy in thyroid malignant neoplasms. Arch Surg (1998) 1.12

Developmental programming: deficits in reproductive hormone dynamics and ovulatory outcomes in prenatal, testosterone-treated sheep. Biol Reprod (2007) 1.11

Reduction of inflammatory response in the mouse brain with adenoviral-mediated transforming growth factor-ss1 expression. Stroke (2001) 1.11

Antioxidants and cancers of the esophagus and gastric cardia. Int J Cancer (2000) 1.11

Detection of occult metastatic breast cancer cells in blood by a multimolecular marker assay: correlation with clinical stage of disease. Cancer Res (2001) 1.09

Intestinal cancer after cholecystectomy: is bile involved in carcinogenesis? Gastroenterology (2001) 1.09

FOXC1 regulates the functions of human basal-like breast cancer cells by activating NF-κB signaling. Oncogene (2012) 1.08

Diabetes mellitus, glycated haemoglobin and C-peptide levels in relation to pancreatic cancer risk: a study within the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort. Diabetologia (2011) 1.08

Evidence for a particle produced in association with weak bosons and decaying to a bottom-antibottom quark pair in higgs boson searches at the tevatron. Phys Rev Lett (2012) 1.08

Margin status and local recurrence after breast-conserving surgery. Arch Surg (1994) 1.08

Sentinel node metastasis in patients with breast carcinoma accurately predicts immunohistochemically detectable nonsentinel node metastasis. Ann Surg Oncol (1999) 1.07

Association between cholecystectomy and adenocarcinoma of the esophagus. Gastroenterology (2001) 1.06

The autoimmune spectrum of myasthenia gravis: a Swedish population-based study. J Intern Med (2014) 1.06

Lung cancer risk in a population-based cohort of patients hospitalized for asthma in Sweden. Eur Respir J (2002) 1.05

The risk of liver and bile duct cancer in patients with chronic viral hepatitis, alcoholism, or cirrhosis. Hepatology (2001) 1.04

Signal pathways involved in apigenin inhibition of growth and induction of apoptosis of human anaplastic thyroid cancer cells (ARO). Anticancer Res (2000) 1.04

Matrix metalloproteinase inhibitors: a structure-activity study. J Med Chem (1998) 1.03

Primary brain tumors following traumatic brain injury--a population-based cohort study in Sweden. Cancer Causes Control (2001) 1.03

Oncofetal antigen: a tumor-associated fetal antigen immunogenic in man. J Natl Cancer Inst (1979) 1.02

Prospective study of body size and risk for stroke amongst women below age 60. J Intern Med (2006) 1.01

Uncoupling ceramide glycosylation by transfection of glucosylceramide synthase antisense reverses adriamycin resistance. J Biol Chem (2000) 1.01

Growth inhibitory effects of flavonoids in human thyroid cancer cell lines. Thyroid (1999) 1.01

Sentinel lymphadenectomy in primary breast carcinoma: an alternative to routine axillary dissection. J Surg Oncol (1996) 1.01

Incidence of cancer among patients with hidradenitis suppurativa. Arch Dermatol (2001) 1.01

Detection of metastases in sentinel lymph nodes of breast cancer patients by multiple-marker RT-PCR. Int J Cancer (1998) 1.00

Thalidomide and thalidomide analogs reduce HIV type 1 replication in human macrophages in vitro. AIDS Res Hum Retroviruses (1997) 0.99

Attenuation of ischemia-induced mouse brain injury by SAG, a redox-inducible antioxidant protein. J Cereb Blood Flow Metab (2001) 0.99

Hospitalisation of and mortality from bleeding peptic ulcer in Sweden: a nationwide time-trend analysis. Aliment Pharmacol Ther (2011) 0.97

Pathologic examination of sentinel lymph node for breast carcinoma. World J Surg (2001) 0.97

Heredity and risk of cancer of the esophagus and gastric cardia. Cancer Epidemiol Biomarkers Prev (2000) 0.97

Stimulation of adenosine A3 receptors in cerebral ischemia. Neuronal death, recovery, or both? Ann N Y Acad Sci (1999) 0.97

The operative management of coexisting thyroid and parathyroid disease. Arch Surg (1990) 0.96

See one, do twenty-five, teach one: the implementation of sentinel node dissection in breast cancer. Ann Surg Oncol (1999) 0.96

LDH and melanoma. Cancer (1983) 0.96

Practical aspects in the diagnosis and management of cystosarcoma phyllodes. Arch Surg (1988) 0.96

Plasma pepsinogens, antibodies against Helicobacter pylori, and risk of gastric cancer in the Shanghai Women's Health Study Cohort. Br J Cancer (2011) 0.95

The detection of breast carcinoma micrometastases in axillary lymph nodes by means of reverse transcriptase-polymerase chain reaction. Cancer (1995) 0.95

Activation of mitogen-activated protein kinases after permanent cerebral artery occlusion in mouse brain. J Cereb Blood Flow Metab (2000) 0.95

Inflammation marker and risk of pancreatic cancer: a nested case-control study within the EPIC cohort. Br J Cancer (2012) 0.95

Changing metastatic patterns of osteosarcoma. Cancer (1984) 0.94

Utility of endoscopic screening for upper gastrointestinal adenocarcinoma. JAMA (2000) 0.94

Results of ilioinguinal dissection for stage II melanoma. Ann Surg (1982) 0.94

Modification of ceramide metabolism increases cancer cell sensitivity to cytotoxics. Int J Oncol (1999) 0.93

Factors affecting sentinel node localization during preoperative breast lymphoscintigraphy. J Nucl Med (2000) 0.92

Lymphatic mapping and sentinel node biopsy in breast cancer. JAMA (1997) 0.92

New cycloartane glycosides from Cimicifuga dahurica. Planta Med (1999) 0.92